Your browser doesn't support javascript.
loading
Bipolar Disorder.
Bauer, Mark S.
Afiliación
  • Bauer MS; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Ann Intern Med ; 175(7): ITC97-ITC112, 2022 07.
Article en En | MEDLINE | ID: mdl-35816713
ABSTRACT
Bipolar disorder (BD) affects approximately 2% of U.S. adults and is the most costly mental health condition for commercial insurers nationwide. Rates of BD are elevated among persons with depression, anxiety disorders, and substance use disorders-conditions frequently seen by primary care clinicians. In addition, antidepressants can precipitate manic or hypomanic symptoms or rapid cycling in persons with undiagnosed BD. Thus, screening in these high-risk groups is indicated. Effective treatments exist, and many can be safely and effectively administered by primary care clinicians.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastorno Bipolar Tipo de estudio: Diagnostic_studies Idioma: En Revista: Ann Intern Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastorno Bipolar Tipo de estudio: Diagnostic_studies Idioma: En Revista: Ann Intern Med Año: 2022 Tipo del documento: Article